Submitted by Anonymous (not verified) on 9 February 2026 - 16:50
Human medicines European public assessment report (EPAR): Datroway, datopotamab deruxtecan, Date of authorisation: 04/04/2025, Revision: 4, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Datroway, datopotamab deruxtecan, Date of authorisation: 04/04/2025, Revision: 4, Status: Authorised